Digital gastrointestinal care startup Salvo Health introduced it closed a $5 million Seed Prime spherical led by Metropolis Mild Capital and Human Ventures led the spherical.
The corporate’s current traders additionally participated within the spherical, together with Torch Capital, Threshold Ventures and Felicis Ventures. Angel traders Anmol Madan, founding father of Ginger Well being and Teladoc’s former chief knowledge scientist additionally contributed.
Emily Melton of Threshold, Rachel Parlier of Metropolis Mild and Salvo founder and CEO Jeffrey Glueck will be a part of Salvo’s board of administrators.
WHAT IT DOES
The New York-based firm affords a digital clinic geared towards individuals with persistent gastrointestinal and metabolic liver points, together with celiac illness, fatty liver illness, irritable bowel syndrome (IBS), gastroesophageal reflux illness (GERD), small intestinal bacterial overgrowth (SIBO) and dyspepsia.
The corporate says it affords “wraparound care” in a hybrid method, which permits sufferers to proceed below their native doctor and entry Salvo’s app-based help.
Via Salvo, customers are matched with a care workforce made up of registered dietitians, behavioral well being specialists and licensed nurses. On this method, they will obtain insurance-covered interdisciplinary care.
The corporate will use the funds to scale its wraparound GI companies to suppliers, together with accountable care organizations, gastroenterology personal practices and well being techniques.
“I’m delighted to steer this funding in Salvo Well being and their revolutionary wraparound take care of GI and metabolic persistent situations,” Parlier of Metropolis Mild Capital mentioned in a press release. “As an early-stage influence investor, we search for firms with the potential to not simply remodel industries, but additionally to enhance lives. Salvo is enabling GI practices and well being techniques to fill within the gaps for underserved affected person populations, particularly for high-touch follow-on care between appointments and post-procedures.”
MARKET SNAPSHOT
Salvo launched in 2022 with $10.5 million in funding to scale its digital clinic for persistent GI situations.
Different firms within the digital digestive care area embrace Vivante Health, which secured $31 million in funding in September, and Oshi Health, which garnered $30 million in Series B funding in April.
“Streamlining AI-Enabled Digital Well being Applied sciences From Analysis to Implementation” is scheduled for Tuesday, March 12, 1:30-2:30 p.m. ET, in W304A at HIMSS24 in Orlando. Learn more and register.
